Delivery Order SPE2DB22D1106-SPE2DB25FDTE1
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,322.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML intravenous infusion bottles (100 mL). The award is not designated as a set-aside contract.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,053.20 firm fixed-price delivery order is for the supply of OMNIPAQUE 180 MG/ML VIAL 10ML, a medical product used for various healthcare applications. The contract has an ultimate completion date of March 30, 2023.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,368.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML Infusion Bottles (100 ML) and does not have a set-aside designation.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Omnipaque 350 mg/ml infusion bottles to the Defense Logistics Agency (DLA). The $1,625.20 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen is a subsidiary of the parent company, Cencora, Inc. The contract has no set-aside designation, indicating open competition.
Amerisourcebergen holds a significant...
This federal contract award is for the delivery of Omnipaque 240 mg/ml vial 10ml pharmaceutical products to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,669.70 firm fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
This federal contract award, valued at $1,218.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipaque 350 mg/ml infusion bottles, a critical pharmaceutical product.
The award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,134.59 firm-fixed-price delivery order is for the supply of Omnipaque 300 mg/ml infusion bottles, a critical medical supply.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical for delivering a comprehensive range of pharmaceutical and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Omnipaque 300 mg/ml medical products. The $1,630.09 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical. The IDC, which runs through November 2026, enables the DLA to efficiently procure a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,197.84 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a period of performance through October 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.38 firm fixed-price delivery order is for the supply of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a period of performance through October 2024. This contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen holds a significant $999,999,999...